Pentobarbital
Specifications
76-74-4CAS Number
200-983-8EC Number
5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trioneIUPAC Name
C11H18N2O3Chemical Formula
226.27 g/molMolecular Weight
pentobarbital; Pentobarbitone; Nembutal; Mebubarbital; Pentobarbituric acid; Ethaminal; Dorsital; Mebumal; 76-74-4; Rivadorm; Pentobarbiturate; Pentabarbitone; Neodorm (new); Pentabarbital; Pentobarbitalum; 5-Ethyl-5-(1-methylbutyl)barbituric acid; 5-Ethyl-5-(sec-pentyl)barbituric acid; 5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione; 5-Ethyl-5-(1-methylbutyl)malonylurea; NSC 28708; Pentobarbital cii; 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-; Barbituric acid, 5-ethyl-5-(1-methylbutyl)-; DTXSID7023435; NSC-28708; CHEMBL448; 5-ethyl-5-(pentan-2-yl)-1,3-diazinane-2,4,6-trione; Aethaminalum; 5-ethyl-5-(pentan-2-yl)pyrimidine-2,4,6(1H,3H,5H)-trione; I4744080IR; Nembutal (VAN); DEA No. 2270; NCGC00096074-01; Pentobarbitale; Pentobarbital (VAN); Pentobarbitone (VAN); Pentobarbitale [DCIT]; 5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione; Pentobarbitalum [INN-Latin]; Phetobarbitone; Pentobarbital (1mg/ml in Methaniol); Pentobarbital (1mg/ml in Acetonitrile); Nembutal (TN); Ethyl-propylmethylcarbinylbarbituric acid; CCRIS 7089; Pentobarbital [INN]; HSDB 3151; EINECS 200-983-8; Pentobarbital (USP/INN); BRN 0087067; 5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione; Barbituric acid, 5-ethyl-5-(2-pentyl)-; Pentobarbital [USP:INN:BAN]; SR-01000317092; UNII-I4744080IR; (+-)-5-Ethyl-5-(1-methylbutyl)barbituric acid; (RS)-pentobarbital; Continal (Salt/Mix); (plusmn)-pentobarbital; Sedalixir (Salt/Mix); Spectrum_001783; Spectrum2_001991; Spectrum3_001783; Spectrum4_000574; Spectrum5_001705; PENTOBARBITAL [MI]; EC 200-983-8; (.+/-.))-Pentobarbital; PENTOBARBITAL [HSDB]; Pentobarbital CRS - * psy; Oprea1_143902; Oprea1_775730; SCHEMBL24966; BSPBio_003305; KBioGR_001008; KBioSS_002267; PENTOBARBITAL [VANDF]; 5-24-09-00168 (Beilstein Handbook Reference); DivK1c_000992; PENTOBARBITAL [MART.]; SPECTRUM1900006; SPBio_002201; PENTOBARBITAL [WHO-DD]; CHEBI:7983; DTXCID003435; GTPL5480; SCHEMBL11114711; component of Emesert (Salt/Mix); component of Synirin (Salt/Mix); HMS503G05; KBio1_000992; KBio2_002266; KBio2_004834; KBio2_007402; KBio3_002807; NINDS_000992; HMS2094E21; HMS3713B10; PENTOBARBITAL [GREEN BOOK]; Pharmakon1600-01900006; PENTOBARBITAL [ORANGE BOOK]; PENTOBARBITAL CII [USP-RS]; NSC28708; PENTOBARBITAL [EP MONOGRAPH]; Tox21_111555; 5-ethyl-2-hydroxy-5-(1-methylbutyl)pyrimidine-4,6(1H,5H)-dione; BDBM50055935; CCG-39476; NSC760434; PENTOBARBITAL [USP MONOGRAPH]; Pentobarbital 0.1 mg/ml in Methanol; Pentobarbital 1.0 mg/ml in Methanol; 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-, (+-)-; AKOS000277861; AKOS028114301; WLN: T6VMVMV FHJ FY3&1 F2; CCG-220564; DB00312; NSC-760434; CAS-76-74-4; IDI1_000992; NCGC00096074-02; NCGC00344563-01; Pentobarbital (1 mg/ml in Acetonitrile); SBI-0052713.P002; DB-056119; NS00008670; C07422; D00499; Q409632; SR-05000001789; THIOPENTAL SODIUM IMPURITY B [EP IMPURITY]; SR-01000317092-2; SR-05000001789-1; BRD-A44448661-001-01-4; BRD-A44448661-001-04-8; (+/-)-5-ETHYL-5-(1-METHYLBUTYL)BARBITURIC ACID; 2,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-; 5-Ethyl-5-(1-methylbutyl)-2,6(1H,3H,5H)-pyrimidinetrione; Pentobarbital, European Pharmacopoeia (EP) Reference Standard; Pentobarbital, United States Pharmacopeia (USP) Reference Standard; pyrimidine-2,4,6(1H,3H,5H)-trione, 5-ethyl-5-(1-methylbutyl)-; 2,4,6(1H,3H,5H)-PYRIMIDINETRIONE, 5-ETHYL-5-(1-METHYLBUTYL)-, (+/-)-Synonyms
